Management of burning mouth syndrome: systematic review and management recommendations (Q34611332)

3 August 2017

1 reference

title

Management of burning mouth syndrome: systematic review and management recommendations (English)

1 reference

management recommendation

3 August 2017

1 reference

burning mouth syndrome

1 reference

based on heuristic

inferred from title

1 reference

Lauren L Patton

1

0 references

author name string

Michael A Siegel

series ordinal

2

1 reference

3 August 2017

Raphael Benoliel

series ordinal

3

1 reference

3 August 2017

Antoon De Laat

series ordinal

4

1 reference

3 August 2017

publication date

1 March 2007

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

3 August 2017

published in

1 reference

3 August 2017

volume

103 Suppl

1 reference

3 August 2017

page(s)

S39.e1-13

1 reference

Burning mouth syndrome: prevalence and associated factors.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Update on burning mouth syndrome: overview and patient management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Antecedents of burning mouth syndrome (glossodynia)--recent life events vs. psychopathologic aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

The International classification of headache disorders, 2nd edn (ICDH-II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Stomatodynia (burning mouth) as a complication of enalapril therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Candida-induced stomatopyrosis and its relation to diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Burning Mouth Syndrome: An Update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Oral symptoms at menopause--the role of hormone replacement therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Relationships between age, drugs, oral sensorial complaints and salivary profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

The burning mouth syndrome remains an enigma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Oral manifestations of previously undiagnosed non-insulin dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Estimated prevalence and distribution of reported orofacial pain in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Burning mouth in a Finnish adult population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Clinical characteristics and management outcome in the burning mouth syndrome. An open study of 130 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

The secretion of parotid saliva as stimulated by 10% citric acid is not related to precipitating factors in burning mouth syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Biochemical analysis of saliva and taste acuity evaluation in patients with burning mouth syndrome, xerostomia and/or gustatory disturbances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Oral mucosal blood flow in patients with burning mouth syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Association between regional idiopathic neuropathy and salivary involvement as the possible mechanism for oral sensory complaints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

The effects of topical anesthesia on oral burning in burning mouth syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Taste function in patients with oral burning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Psychophysical assessment of tactile, pain and thermal sensory functions in burning mouth syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Pain threshold and pain recovery after experimental stimulation in patients with burning mouth syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Sensory dysfunction in burning mouth syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Burning mouth syndrome and other oral sensory disorders: a unifying hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Abnormalities of the blink reflex in burning mouth syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Striatal dopamine D1 and D2 receptors in burning mouth syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Ovarian steroids regulate neuropeptides in the trigeminal ganglion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Effects of oestrogen on trigeminal ganglia in culture: implications for hormonal effects on migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Chronic pain and psychopathology: research findings and theoretical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Personality characteristics of patients with resistant burning mouth syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Vulnerability and presenting symptoms in burning mouth syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Interventions for the treatment of burning mouth syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Antidepressants for neuropathic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Topical clonazepam in stomatodynia: a randomised placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. A clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Burning mouth syndrome. Critical review and proposed clinical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Psychological approaches in chronic pain management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Role of psychology in pain management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Outpatient cognitive behavioral pain management programs: a randomized comparison of a group-based multidisciplinary versus an individual therapy model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRIPLEO.2006.11.009

1 reference

3 August 2017

1 reference